Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient
Medication-induced cutaneous hyperpigmentation has variable clinical presentations and is dependent on the specific drug involved. Most commonly, an attentive patient observes such changes early in the course; when missed by the patient, such changes are usually noted by an observant clinician. Clin...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Medicine |
| Online Access: | http://dx.doi.org/10.1155/2020/6186471 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832554033579032576 |
|---|---|
| author | Shakuntala S. Patil Sachin M. Patil Ryan Campbell Manisha Singh Matthew Plotkin |
| author_facet | Shakuntala S. Patil Sachin M. Patil Ryan Campbell Manisha Singh Matthew Plotkin |
| author_sort | Shakuntala S. Patil |
| collection | DOAJ |
| description | Medication-induced cutaneous hyperpigmentation has variable clinical presentations and is dependent on the specific drug involved. Most commonly, an attentive patient observes such changes early in the course; when missed by the patient, such changes are usually noted by an observant clinician. Clinical diagnosis can be challenging if the patient is on multiple medications because other causes must be excluded. This condition occurs via multiple mechanisms. Frequently, the pigmentary change is reversible with discontinuation of the drug. Causative medications include nonsteroidal; anti-inflammatory agents, antimalarials, antibiotics, psychotropics, amiodarone, and chemotherapeutic agents. The; antimicrobials responsible for hyperpigmentation are antimalarials, tetracyclines, tigecycline, dapsone, rifampicin, and antiretrovirals such as zidovudine. Sunlight exposure can worsen the pigmentation seen with some of the above antimicrobials (e.g., dapsone). Here, we describe an older adult white woman presenting with acute cutaneous; hyperpigmentation of the bilateral lower extremities while on levofloxacin therapy. Hyperpigmentation resolved after cessation of the agent. Our case highlights this unique acute presentation after only a few days of oral levofloxacin. |
| format | Article |
| id | doaj-art-ac74f2363ebb471798fc9a1184d884ac |
| institution | Kabale University |
| issn | 1687-9627 1687-9635 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Medicine |
| spelling | doaj-art-ac74f2363ebb471798fc9a1184d884ac2025-02-03T05:52:34ZengWileyCase Reports in Medicine1687-96271687-96352020-01-01202010.1155/2020/61864716186471Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease PatientShakuntala S. Patil0Sachin M. Patil1Ryan Campbell2Manisha Singh3Matthew Plotkin4University of Missouri Hospital and Clinic, 1 Hospital Drive, Columbia, MO 65212, USAUniversity of Missouri Hospital and Clinic, 1 Hospital Drive, Columbia, MO 65212, USAUniversity of Missouri Hospital and Clinic, 1 Hospital Drive, Columbia, MO 65212, USAUniversity of Missouri Hospital and Clinic, 1 Hospital Drive, Columbia, MO 65212, USAUniversity of Missouri Hospital and Clinic, 1 Hospital Drive, Columbia, MO 65212, USAMedication-induced cutaneous hyperpigmentation has variable clinical presentations and is dependent on the specific drug involved. Most commonly, an attentive patient observes such changes early in the course; when missed by the patient, such changes are usually noted by an observant clinician. Clinical diagnosis can be challenging if the patient is on multiple medications because other causes must be excluded. This condition occurs via multiple mechanisms. Frequently, the pigmentary change is reversible with discontinuation of the drug. Causative medications include nonsteroidal; anti-inflammatory agents, antimalarials, antibiotics, psychotropics, amiodarone, and chemotherapeutic agents. The; antimicrobials responsible for hyperpigmentation are antimalarials, tetracyclines, tigecycline, dapsone, rifampicin, and antiretrovirals such as zidovudine. Sunlight exposure can worsen the pigmentation seen with some of the above antimicrobials (e.g., dapsone). Here, we describe an older adult white woman presenting with acute cutaneous; hyperpigmentation of the bilateral lower extremities while on levofloxacin therapy. Hyperpigmentation resolved after cessation of the agent. Our case highlights this unique acute presentation after only a few days of oral levofloxacin.http://dx.doi.org/10.1155/2020/6186471 |
| spellingShingle | Shakuntala S. Patil Sachin M. Patil Ryan Campbell Manisha Singh Matthew Plotkin Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient Case Reports in Medicine |
| title | Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient |
| title_full | Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient |
| title_fullStr | Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient |
| title_full_unstemmed | Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient |
| title_short | Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient |
| title_sort | levofloxacin induced acute hyperpigmentation changes in a chronic kidney disease patient |
| url | http://dx.doi.org/10.1155/2020/6186471 |
| work_keys_str_mv | AT shakuntalaspatil levofloxacininducedacutehyperpigmentationchangesinachronickidneydiseasepatient AT sachinmpatil levofloxacininducedacutehyperpigmentationchangesinachronickidneydiseasepatient AT ryancampbell levofloxacininducedacutehyperpigmentationchangesinachronickidneydiseasepatient AT manishasingh levofloxacininducedacutehyperpigmentationchangesinachronickidneydiseasepatient AT matthewplotkin levofloxacininducedacutehyperpigmentationchangesinachronickidneydiseasepatient |